More Healthcare Coverage

  • February 12, 2024

    Geico Says Medical Fraudsters Nabbed $1.1M In Auto Benefits

    Several unlicensed individuals submitted hundreds of fraudulent charges for services provided to Geico-insured car accident victims, the insurer has alleged in New York federal court, claiming it lost more than $1.1 million in the no-fault insurance fraud scheme.

  • February 12, 2024

    Health Atty Rejoins Troutman Pepper After Solo Practice Stint

    An attorney who specializes in representing life sciences companies in commercial and operational matters has left her solo practice to join Troutman Pepper in Philadelphia, the firm said Monday.

  • February 09, 2024

    Conn. Judge Guts Healthcare Staffing Co. Partnership Suit

    Citing a lack of subject matter jurisdiction, a Connecticut state court judge has dismissed most of a lawsuit alleging a healthcare staffing firm's part-owner plundered the business, concluding only a dissolution claim should survive.

  • February 09, 2024

    5th Circ. Orders Court To Find Who Benefits From Free Work

    Courts tasked with determining whether drug rehabilitation program participants who perform labor as part of their treatment are employees with rights to wages must determine who primarily benefits from the unpaid work, the Fifth Circuit ruled Friday.

  • February 09, 2024

    Pharma Co. Beats Investor Suit Over Licensing Agreement

    A New York federal judge has dismissed a proposed investor class action against pharmaceutical company Molecular Partners, ruling the plaintiff failed to show the company misled investors about its progress in the development of a cancer treatment.

  • February 08, 2024

    Service Failure On Expert Reports Dooms Texas Med Mal Case

    A medical malpractice suit over the death of a man admitted to a medical center for stomach pain will not move forward because two expert reports and accompanying curriculum vitae were not served on the defendant's doctor and facility quickly enough, a Texas appellate panel ruled Thursday.

  • February 08, 2024

    Dentists In $13B Delta Dental Suit Want Class Status

    Dental providers claiming the nation's largest dental insurance system and its members engaged in a $13 billion scheme to restrict competition and lower reimbursement rates told an Illinois federal judge their claims deserve class treatment because common evidence will prove both the alleged conspiracy and its impact.

  • February 08, 2024

    Seattle Hospital Owes $215K In Mold Suit, Jury Finds

    A Seattle jury awarded $215,000 Thursday to three families whose children were prescribed antifungal treatment after being potentially exposed to toxic mold at Seattle Children's Hospital, concluding a bellwether damages trial and rejecting plaintiffs' request for far more. 

  • February 08, 2024

    Philips Rival Seeks Interest After Treble Damages Award

    A medical equipment supplier that nabbed treble damages against Philips Medical Systems after a split verdict in a wide-ranging copyright and unfair competition case is now asking for at least six figures in interest, despite a judge previously denying a similar request by Philips.

  • February 07, 2024

    Med Mal Case Dropped Before Wash. Justices Decide Blame

    A woman treated for injuries from a car crash has dropped her malpractice lawsuit against a hospital and a doctor, in a case a federal judge sent to the Washington Supreme Court to decide if the hospital could partially blame the patient for her injuries because she was driving while intoxicated.

  • February 07, 2024

    Wash. High Court Won't Review J&J Patient Privacy Ruling

    The Washington State Supreme Court won't review a ruling blocking Johnson & Johnson from seeing data on millions of patients in a suit over the opioid epidemic, just weeks after the drugmaker struck a $150 million deal with the state to end the litigation.

  • February 07, 2024

    Conn. Justices OK $35M Verdict, Punt On 'Wrongful Life'

    Though it declined to resolve a trial court split over wrongful life actions, the Connecticut Supreme Court has upheld a $34.6 million malpractice verdict after a fertility procedure at University of Connecticut Health Center ended with the death of one infant before birth and lifelong complications for another.

  • February 07, 2024

    Investor Wants Fla. CBD Co.'s Atty DQ'd In Fraud Suit

    An investor in a Florida health goods company asked a federal judge Wednesday to disqualify an attorney from representing a company principal, saying the attorney should instead testify at trial because he knows about relevant contract negotiations.

  • February 07, 2024

    Marshall Dennehey Adds Med Mal Pro In Pittsburgh

    An attorney with more than three decades of experience in medical malpractice litigation has moved her practice to Marshall Dennehey's Pittsburgh office after more than five years of practicing with Davis McFarland & Carroll LLC.

  • February 06, 2024

    Seattle Hospital Must Pay Up For 'Huge' Negligence, Jury Told

    Counsel for three families whose children had to undergo anti-fungal treatment after a Seattle hospital exposed them to mold urged a Washington state jury Tuesday to aim high on their damages award during closing arguments in a bellwether trial, citing lasting consequences that merit more than "a couple hundred thousand dollars."

  • February 06, 2024

    2nd Circ. Gives Physician's Disability Bias Suit New Life

    The Second Circuit revived a fertility doctor's lawsuit alleging a Vermont hospital terminated her because she took medical leave for a cerebrospinal fluid leak, finding Tuesday a lower court erroneously overlooked that supervisors referenced her disability when explaining why she was let go.

  • February 06, 2024

    Judge Accepts DHA's Course-Correct For $65B Tricare Deal

    The U.S. Court of Federal Claims explained Tuesday why it cleared an embattled deal for healthcare services for the U.S. Department of Defense, saying the department appropriately handled claims challenging the winning company's small business participation plan.

  • February 06, 2024

    Judge Won't Toss All Claims In COVID Test Securities Action

    A New York federal judge trimmed a proposed class action against COVID-19 test-maker Co-Diagnostics and its executives, but said investors sufficiently alleged some statements made during the class period misrepresented that sales and demand for the tests were on the decline, and the defendants knew as such.

  • February 06, 2024

    Committees Send PBM, Preventive Health Bills To House

    Two congressional committees sent separate legislation on Tuesday to the House after holding committee markup votes, moving forward bills that could allow Congress to examine if preventive healthcare might reduce Congressional spending and to address transparency for prescription benefit managers and potentially drive down the cost of prescription drugs.  

  • February 06, 2024

    Appeals Court Upholds Insurers' COVID-19 Coverage Win

    A Texas state appeals court upheld on Tuesday a decision that a pollution and contamination exclusion prevents coverage for Baylor College of Medicine's COVID-19-related losses.

  • February 06, 2024

    JPML Consolidates Suboxone Dental Decay Suits In Ohio

    The Northern District of Ohio will host consolidated cases brought against Indivior, Reckitt Benckiser and others alleging the companies failed to warn users of opioid addiction treatment Suboxone that it causes dental decay, according to an order from the U.S. Judicial Panel on Multidistrict Litigation joining 15 suits.

  • February 06, 2024

    NC Virus Law Won't Free Surgeon From Med Mal Suit, Panel Says

    North Carolina's COVID-19 emergency law cannot shield a doctor and hospital from a patient's lawsuit alleging she nearly died from a botched hysterectomy, a state appeals court ruled Tuesday, reasoning the medical providers didn't show how the virus affected the patient's treatment.

  • February 05, 2024

    States Ask Justices To End Feds' Alleged Online Censorship

    The Biden administration is trying to "flip the First Amendment on its head" by arguing that the government has free speech rights that are being trampled by an order banning it from working with social media companies to combat disinformation, Louisiana and Missouri have told the U.S. Supreme Court.

  • February 05, 2024

    JCPenney Cardholder's Proposed $5M Insurance Suit Fails

    A JCPenney credit card holder who bought health insurance through a promotion tied to the card lost her bid in Mississippi federal court Monday to continue her $5 million proposed class action over what she believed were intentional delays in paying for her hospital stay.

  • February 05, 2024

    Merck's Former CEO And GC Joins Harvard Board

    Kenneth Frazier, who rose in the ranks at Merck & Co. to become general counsel and eventual CEO and chair, will soon join the Harvard Corporation governing board, according to an announcement Sunday, as the Ivy League university continues to look for a new president.

Expert Analysis

  • What FTC's Data Actions Say About Tracker Enforcement

    Author Photo

    The Federal Trade Commission’s recent enforcement actions against GoodRx and BetterHelp for sharing sensitive user information show the agency may be setting a new standard for the collection, use and disclosure of user data, which should prompt companies to audit their use of — and policies regarding — data trackers, says Reed Freeman at ArentFox Schiff.

  • Labor Collusion Loss Will Shape DOJ's Case Strategy

    Author Photo

    Following the U.S. Department of Justice’s recent loss in United States v. Manahe, tallying its trial score record to 0-3 in labor-related antitrust cases over the past year, defendants can expect that the DOJ will try to exclude defense evidence and argue for more favorable jury instructions, say attorneys at Sheppard Mullin.

  • Examining Chancery's Recent Openness To Caremark Claims

    Author Photo

    As seen in an April decision involving Walmart's role in the national opioid epidemic, the Delaware Chancery Court has recently shown receptivity to Caremark claims at the early pleading stage of litigation, providing plaintiffs with more leverage to negotiate an early settlement and bringing risk management lessons for boards, say attorneys at Fried Frank.

  • Expect The Patchwork Of AI Regulation To Grow

    Author Photo

    Given the unlikelihood of meaningful federal artificial intelligence legislation in the immediate future, the patchwork of state AI regulation will likely continue to grow, bringing at least two main risks for companies in the AI space, say attorneys at Jenner & Block.

  • Job Reassignment Case Shows Need For Clear ADA Policies

    Author Photo

    The Fifth Circuit's recent holding in U.S. Equal Employment Opportunity Commission v. Methodist Hospitals that a disabled employee was not entitled to a job reassignment as a reasonable accommodation underscores the importance of implementing detailed Americans with Disabilities Act policies and educating employees on them, says Marcellus Chamberlain at Phelps Dunbar.

  • White Collar Defense Lessons From The Bench And Beyond

    Author Photo

    Former Minnesota judge and federal prosecutor Nicole Engisch, now a partner at Dorsey & Whitney, shares insights from her background that may inform attorneys’ defense-side approach in white collar cases and corporate investigations — more relevant than ever given the U.S. Department of Justice’s recent policy changes.

  • Comparing Iowa's Data Privacy Law With Other States'

    Author Photo

    Iowa’s recently signed data privacy law is intentionally more business-friendly than other U.S. state privacy laws — as it does not apply in the business-to-business contexts and does not have a private right of action — and further entrenches the main tenets of enhanced privacy in the U.S., say attorneys at Eversheds Sutherland.

  • Ga. Needs To Resolve Cannabis Counsel Confusion

    Author Photo

    Georgia’s medical cannabis regulator finally adopted rules for low-THC oil last month, but a 2021 ethics ruling prohibits lawyers from advising participants in the state’s legal program and creates a confounding landscape that the state bar and courts must address, say Whitt Steineker and Mason Kruze at Bradley Arant.

  • 6th Circ. Ruling's Seismic Shift In FCA Kickback Causation

    Author Photo

    It is difficult to overstate the significance of the Sixth Circuit’s recent decision in the False Claims Act kickback case U.S. v. Hathaway, which shifts the government's burden of proof by adopting a more defense-friendly causation standard and curbing an expansive definition of remuneration, say attorneys at Morgan Lewis.

  • 3rd Circ. Ruling Offers Tools To Manage Exempt Employees

    Author Photo

    The Third Circuit’s recent opinion in Higgins v. Bayada Home Health, finding the Fair Labor Standards Act allows employers to deduct paid time off for missed employee productivity targets, gives companies another resource for managing exempt employee inefficiency or absenteeism, says Laura Lawless at Squire Patton.

  • Dormant Commerce Clause Issues Are Evolving In Cannabis

    Author Photo

    As federal courts across the country wrestle with how the Constitution’s dormant commerce clause applies to state-legal cannabis markets, industry stakeholders will need to watch how the issue evolves in several key contexts, including interstate compacts, say Tommy Tobin and Andrew Kline at Perkins Coie.

  • Garmon Defense Finds New Relevance As NLRB Stays Active

    Author Photo

    With a more muscular National Labor Relations Board at work, employers should recall that they have access to a powerful yet underutilized defense to state law employment and tort claims established under the U.S. Supreme Court decision in San Diego Building Trades Council v. Garmon, say Alex Meier and Cary Reid Burke at Seyfarth.

  • The Important Role Of Contra Proferentem In ERISA Cases

    Author Photo

    A Pennsylvania federal court's recent decision in Stein v. Paul Revere Life Insurance illustrates what happens when ERISA plan terms are unclear, and why the contra proferentem principle should be applied uniformly in all ERISA cases, says Mark DeBofsky at DeBofsky Law.

Can't find the article you're looking for? Click here to search the Healthcare Authority Other archive.